Replies to post #413500 on Anavex Life Sciences Corp (AVXL)

[tredenwater2]

“ In the present and past trials of 2-73 Blarcamesine treating either for AD, PDD, PD, or Rett , they are also potentially treating the heart, lungs, liver, kidneys, colon, eyes. etc. for some degree of improvement.”

Red, great points, imo that is what is taking so long in proving out. They know this which triggered the “tip of the iceberg “ comment long ago and hence the plethora of patent filings and protection over the years. Also supports the comment by Dr, Missling about the “ front end taking longer but it will help accelerate the back end” .

Again to newbies, these trials are proving behind the scenes so much more then the trial disease they are in. It is of my opinion they are going for, ultimately, prophylactic approval , eventually. It might be in maybe 3-4 years and after 1 or 2 approvals but they are building out major new trial structures where the results are justified anecdotally, genomically, and ultimately for investors in the way of returns, huge returns.

Will the market crash forcing investors to liquidate, who knows but only God. Dr. Missling has brought us this far and I for one believe he will bring it home.

[sage4]

Add 'Hypertension' from the PR yesterday to the list.

Hard to believe

[Bourbon_on_my_cornflakes]

SPOT ON: Anyone in the trials getting a 30mg or 50mg daily dose of A2-73 or A3-71 for the treatment of a particular disease, they are also treating all the organs at the same time with the S1-R in homeostasis with the mitochondria.

That is how they are getting cardio data, maybe some glaucoma data. All common in the old, so the data just falls in your lap. Sort of a stealth P2.

So they can design a P2 that is powered up to be a P3, and with approvals for Rett or alz already in the bag, can make the case to the FDA that one test with convincing results is enough for accelerated approval, and then just do the P4.

That could lower the timing on additional indications to 2 years or less.

Also I wonder what is the story with Wayne State's 273 MS trial Seems that could just be written up and submitted as an NDA if 273 already approved for Rett and alz.